Title : Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.

Pub. Date : 2003 Jan-Feb

PMID : 12680177






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: To evaluate the efficacy and safety of weekly paclitaxel and trastuzumab in patients with HER2-positive metastatic breast cancer, with trastuzumab administered beyond disease progression. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 CONCLUSION: Prolonged administration of weekly paclitaxel and trastuzumab is effective and well-tolerated in women with HER2-positive metastatic breast cancer. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens